107 related articles for article (PubMed ID: 12147248)
1. Alteration of cellular phosphorylation state affects vitamin D receptor-mediated CYP3A4 mRNA induction in Caco-2 cells.
Hara H; Yasunami Y; Adachi T
Biochem Biophys Res Commun; 2002 Aug; 296(1):182-8. PubMed ID: 12147248
[TBL] [Abstract][Full Text] [Related]
2. C-jun N-terminal kinase modulates 1,25-dihydroxyvitamin D3-induced cytochrome P450 3A4 gene expression.
Yasunami Y; Hara H; Iwamura T; Kataoka T; Adachi T
Drug Metab Dispos; 2004 Jul; 32(7):685-8. PubMed ID: 15205382
[TBL] [Abstract][Full Text] [Related]
3. Loss of CYP3A7 gene induction by 1,25-dihydroxyvitamin D3 is caused by less binding of VDR to the proximal ER6 in CYP3A7 gene.
Hara H; Yasunami Y; Adachi T
Biochem Biophys Res Commun; 2004 Sep; 321(4):909-15. PubMed ID: 15358113
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of nitric oxide on the induction of cytochrome P450 3A4 mRNA by 1,25-dihydroxyvitamin D3 in Caco-2 cells.
Hara H; Mitani N; Adachi T
Free Radic Res; 2000 Sep; 33(3):279-85. PubMed ID: 10993481
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor is not required for the rapid actions of 1,25-dihydroxyvitamin D3 to increase intracellular calcium and activate protein kinase C in mouse osteoblasts.
Wali RK; Kong J; Sitrin MD; Bissonnette M; Li YC
J Cell Biochem; 2003 Mar; 88(4):794-801. PubMed ID: 12577313
[TBL] [Abstract][Full Text] [Related]
6. Role of c-Myc in nitric oxide-mediated suppression of cytochrome P450 3A4.
Watabe M; Isogai Y; Numazawa S; Yoshida T
Life Sci; 2003 Nov; 74(1):99-108. PubMed ID: 14575816
[TBL] [Abstract][Full Text] [Related]
7. Rapid and drastic induction of CYP3A4 mRNA expression via vitamin D receptor in human intestinal LS180 cells.
Fukumori S; Murata T; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2007 Oct; 22(5):377-81. PubMed ID: 17965521
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.
Thummel KE; Brimer C; Yasuda K; Thottassery J; Senn T; Lin Y; Ishizuka H; Kharasch E; Schuetz J; Schuetz E
Mol Pharmacol; 2001 Dec; 60(6):1399-406. PubMed ID: 11723248
[TBL] [Abstract][Full Text] [Related]
9. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.
Schmiedlin-Ren P; Thummel KE; Fisher JM; Paine MF; Lown KS; Watkins PB
Mol Pharmacol; 1997 May; 51(5):741-54. PubMed ID: 9145912
[TBL] [Abstract][Full Text] [Related]
10. Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor.
Schmiedlin-Ren P; Thummel KE; Fisher JM; Paine MF; Watkins PB
Drug Metab Dispos; 2001 Nov; 29(11):1446-53. PubMed ID: 11602520
[TBL] [Abstract][Full Text] [Related]
11. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
Jurutka PW; Thompson PD; Whitfield GK; Eichhorst KR; Hall N; Dominguez CE; Hsieh JC; Haussler CA; Haussler MR
J Cell Biochem; 2005 Apr; 94(5):917-43. PubMed ID: 15578590
[TBL] [Abstract][Full Text] [Related]
12. Regulation of VDR expression in rat and human intestine and liver--consequences for CYP3A expression.
Khan AA; Dragt BS; Porte RJ; Groothuis GM
Toxicol In Vitro; 2010 Apr; 24(3):822-9. PubMed ID: 20006981
[TBL] [Abstract][Full Text] [Related]
13. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes.
Drocourt L; Ourlin JC; Pascussi JM; Maurel P; Vilarem MJ
J Biol Chem; 2002 Jul; 277(28):25125-32. PubMed ID: 11991950
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
Chen ML; Ray S; Swamy N; Holick MF; Ray R
Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Profiling of 1α,25(OH)
Pavek P; Dusek J; Smutny T; Lochman L; Kucera R; Skoda J; Smutna L; Kamaraj R; Soucek P; Vrzal R; Dvorak Z
Mol Nutr Food Res; 2022 May; 66(9):e2200070. PubMed ID: 35184385
[TBL] [Abstract][Full Text] [Related]
16. Control of 1,25-dihydroxyvitamin D3 receptor-mediated enhancement of osteocalcin gene transcription: effects of perturbing phosphorylation pathways by okadaic acid and staurosporine.
Desai RK; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Endocrinology; 1995 Dec; 136(12):5685-93. PubMed ID: 7588324
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Receptor-Mediated Upregulation of CYP3A4 and MDR1 by Quercetin in Caco-2 cells.
Chae YJ; Cho KH; Yoon IS; Noh CK; Lee HJ; Park Y; Ji E; Seo MD; Maeng HJ
Planta Med; 2016 Jan; 82(1-2):121-30. PubMed ID: 26366751
[TBL] [Abstract][Full Text] [Related]
18. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE
Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037
[TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxyvitamin D3 and TPA activate phospholipase D in Caco-2 cells: role of PKC-alpha.
Khare S; Bissonnette M; Scaglione-Sewell B; Wali RK; Sitrin MD; Brasitus TA
Am J Physiol; 1999 Apr; 276(4):G993-G1004. PubMed ID: 10198344
[TBL] [Abstract][Full Text] [Related]
20. 1alpha,25-dihydroxyvitamin D(3) and 24R,25-dihydroxyvitamin D(3) modulate growth plate chondrocyte physiology via protein kinase C-dependent phosphorylation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase.
Schwartz Z; Ehland H; Sylvia VL; Larsson D; Hardin RR; Bingham V; Lopez D; Dean DD; Boyan BD
Endocrinology; 2002 Jul; 143(7):2775-86. PubMed ID: 12072413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
